SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-004559
Filing Date
2018-01-05
Accepted
2018-01-05 16:46:03
Documents
5
Period of Report
2017-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d513584d8k.htm 8-K 22613
2 EX-10.1 d513584dex101.htm EX-10.1 253052
3 EX-99.1 d513584dex991.htm EX-99.1 18934
4 GRAPHIC g513584g0103163602397.jpg GRAPHIC 2483
5 GRAPHIC g513584g44q89.gif GRAPHIC 3670
  Complete submission text file 0001193125-18-004559.txt   304766
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 18513929
SIC: 2834 Pharmaceutical Preparations